<description>&lt;p&gt;&lt;strong&gt;This episode of the Dementia Researcher Podcast comes from the AD PD Conference 2026 in Copenhagen, bringing together global researchers to share the latest in Alzheimer’s and Parkinson’s disease research.&lt;/strong&gt;&lt;/p&gt;&lt;p&gt;Hosted by &lt;a href="https://www.dementiaresearcher.nihr.ac.uk/profile-dr-david-cash-university-college-london/" rel="noopener noreferrer" target="_blank"&gt;Professor David Cash&lt;/a&gt;, the episode features &lt;a href="https://www.dementiaresearcher.nihr.ac.uk/profile-grace-thomson-university-of-exeter/" rel="noopener noreferrer" target="_blank"&gt;Grace Thompson&lt;/a&gt;, &lt;a href="https://www.dementiaresearcher.nihr.ac.uk/profile-dr-marieta-vassileva-ucl-aruk-drug-discovery-institute/" rel="noopener noreferrer" target="_blank"&gt;Dr Marieta Vassileva&lt;/a&gt;, and &lt;a href="https://www.dementiaresearcher.nihr.ac.uk/profile-dr-alice-carstairs-alzheimers-society/" rel="noopener noreferrer" target="_blank"&gt;Dr Alice Carstairs&lt;/a&gt;, each offering their own highlights from across the conference.&lt;/p&gt;&lt;p&gt;Rather than trying to cover everything, the conversation focuses on standout talks and emerging themes. These include advances in biomarkers, growing interest in co pathology, the role of neuroinflammation, and how new tools like AI and multiomics are changing how we understand disease.&lt;/p&gt;&lt;p&gt;Across the discussion, the group reflects on what new findings might mean for diagnosis, treatment, and the future direction of dementia research. There is also a strong sense of optimism, with the field moving towards combination therapies and earlier intervention.&lt;/p&gt;&lt;p&gt;This is Part One of a two part series capturing reflections from the conference.&lt;/p&gt;&lt;p&gt;ADPD Conference Website - &lt;a href="https://gate.sc/?url=https%3A%2F%2Fadpd.kenes.com%2F&amp;amp;token=6569cf-1-1775058741517" rel="noopener noreferrer" target="_blank"&gt;adpd.kenes.com/&lt;/a&gt;&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Top Takeaways:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;Biomarkers are now central across diagnosis, prediction, and trials&lt;/li&gt;&lt;li&gt;Co pathology is a major theme, with diseases rarely existing in isolation&lt;/li&gt;&lt;li&gt;Tau is emerging as a key driver of cognitive decline&lt;/li&gt;&lt;li&gt;Microglia and neuroinflammation offer new therapeutic targets&lt;/li&gt;&lt;li&gt;Multiomics is helping uncover detailed disease mechanisms&lt;/li&gt;&lt;li&gt;AI is becoming essential for handling complex datasets&lt;/li&gt;&lt;li&gt;Early career researchers are playing a visible role at major conferences&lt;/li&gt;&lt;li&gt;Synaptic loss is strongly linked to cognitive decline&lt;/li&gt;&lt;li&gt;Combination therapies are increasingly seen as the future&lt;/li&gt;&lt;li&gt;The field feels more optimistic than in previous years&lt;/li&gt;&lt;/ul&gt;&lt;br/&gt;&lt;p&gt;A transcript of this show, links and show notes and profile on all our guests are available on our website at &lt;a href="https://gate.sc/?url=https%3A%2F%2Fwww.dementiaresearcher.nihr.ac.uk&amp;amp;token=6707e1-1-1775058741517" rel="noopener noreferrer" target="_blank"&gt;www.dementiaresearcher.nihr.ac.uk&lt;/a&gt;&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Follow us on social media:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;&lt;a href="https://gate.sc/?url=https%3A%2F%2Fwww.instagram.com%2Fdementia_researcher%2F&amp;amp;token=e2c162-1-1775058741517" rel="noopener noreferrer" target="_blank"&gt;www.instagram.com/dementia_researcher/&lt;/a&gt;&lt;/li&gt;&lt;li&gt;&lt;a href="https://gate.sc/?url=https%3A%2F%2Fwww.facebook.com%2FDementia.Researcher%2F&amp;amp;token=9fdf4d-1-1775058741517" rel="noopener noreferrer" target="_blank"&gt;www.facebook.com/Dementia.Researcher/&lt;/a&gt;&lt;/li&gt;&lt;li&gt;&lt;a href="https://gate.sc/?url=https%3A%2F%2Fwww.twitter.com%2Fdemrescommunity&amp;amp;token=5f3f47-1-1775058741517" rel="noopener noreferrer" target="_blank"&gt;www.twitter.com/demrescommunity&lt;/a&gt;&lt;/li&gt;&lt;li&gt;&lt;a href="https://gate.sc/?url=https%3A%2F%2Fwww.linkedin.com%2Fcompany%2Fdementia-researcher&amp;amp;token=5b4ad7-1-1775058741517" rel="noopener noreferrer" target="_blank"&gt;www.linkedin.com/company/dementia-researcher&lt;/a&gt;&lt;/li&gt;&lt;li&gt;&lt;a href="https://gate.sc/?url=https%3A%2F%2Fwww.bsky.app%2Fprofile%2Fdementiare%E2%80%A6archer.bsky.social&amp;amp;token=4f50f8-1-1775058741517" rel="noopener noreferrer" target="_blank"&gt;www.bsky.app/profile/dementiare…archer.bsky.social&lt;/a&gt;&lt;/li&gt;&lt;/ul&gt;&lt;br/&gt;&lt;p&gt;&lt;strong&gt;Download and Register with our Community App:&lt;/strong&gt;&lt;/p&gt;&lt;p&gt;&lt;a href="https://gate.sc/?url=https%3A%2F%2Fwww.onelink.to%2Fdementiaresearcher&amp;amp;token=79e20e-1-1775058741517" rel="noopener noreferrer" target="_blank"&gt;www.onelink.to/dementiaresearcher&lt;/a&gt;&lt;/p&gt;</description>

Dementia Researcher Vodcast

Dementia Researcher

ADPD 2026 Conference Highlights - Part One

MAR 28, 202642 MIN
Dementia Researcher Vodcast

ADPD 2026 Conference Highlights - Part One

MAR 28, 202642 MIN

Description

This episode of the Dementia Researcher Podcast comes from the AD PD Conference 2026 in Copenhagen, bringing together global researchers to share the latest in Alzheimer’s and Parkinson’s disease research.Hosted by Professor David Cash, the episode features Grace Thompson, Dr Marieta Vassileva, and Dr Alice Carstairs, each offering their own highlights from across the conference.Rather than trying to cover everything, the conversation focuses on standout talks and emerging themes. These include advances in biomarkers, growing interest in co pathology, the role of neuroinflammation, and how new tools like AI and multiomics are changing how we understand disease.Across the discussion, the group reflects on what new findings might mean for diagnosis, treatment, and the future direction of dementia research. There is also a strong sense of optimism, with the field moving towards combination therapies and earlier intervention.This is Part One of a two part series capturing reflections from the conference.ADPD Conference Website - adpd.kenes.com/Top Takeaways:Biomarkers are now central across diagnosis, prediction, and trialsCo pathology is a major theme, with diseases rarely existing in isolationTau is emerging as a key driver of cognitive declineMicroglia and neuroinflammation offer new therapeutic targetsMultiomics is helping uncover detailed disease mechanismsAI is becoming essential for handling complex datasetsEarly career researchers are playing a visible role at major conferencesSynaptic loss is strongly linked to cognitive declineCombination therapies are increasingly seen as the futureThe field feels more optimistic than in previous yearsA transcript of this show, links and show notes and profile on all our guests are available on our website at www.dementiaresearcher.nihr.ac.ukFollow us on social media:www.instagram.com/dementia_researcher/www.facebook.com/Dementia.Researcher/www.twitter.com/demrescommunitywww.linkedin.com/company/dementia-researcherwww.bsky.app/profile/dementiare…archer.bsky.socialDownload and Register with our Community App:www.onelink.to/dementiaresearcher